Trial reportNature communications2026
Machine learning model-guided selective use of temporary diverting ileostomy in rectal cancer surgery: a randomized controlled trial.
Trial report in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04999007 (Artificial Intelligence-assisted Decision Making for Temporary Ileostomy), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Artificial Intelligence-assisted Decision Making for Temporary Ileostomy: A Prospective Randomized Controlled Trail.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in oncology: linking biological discovery to clinical utility.Molecular cancer · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
The appropriate use of temporary diverting ileostomy (TDI) in rectal cancer surgery lacks standardized criteria. A randomized controlled trial was performed to evaluate whether the Risk-Guided Temporary Ileostomy Decision (RTID) system, a machine learning-based anastomotic leakage (AL) prediction model, could improve the suitability of TDI utilization. A total of 872 patients with stage I-III rectal cancer undergoing anterior resection were randomized 1:1 to surgeon discretion versus RTID-guided decisions. The final analysis included 750 patients (control, n = 368; RTID, n = 382). The RTID group showed lower overall TDI rate (18.6% vs. 40.5%; P < 0.001) and unnecessary stoma formation (17.7% vs. 41.3%; P < 0.001). Although a numerical increase in necessary TDI use was observed (55.6% vs. 10.0%), this difference was not significant (P = 0.057). Critically, the incidence of the co-primary safety outcome, AL, was comparable between the RTID and control groups (2.4% vs. 2.7%; P = 0.753), indicating that the pre-specified TDI reduction endpoint was met, while the study was underpowered to formally test non-inferiority for AL. RTID offers an objective tool to support TDI decision-making without a compromise in safety. The present study was registered on ClinicalTrials.gov (no. NCT04999007) on August 8, 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.